Crossmark

Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease

Crossref DOI link: https://doi.org/10.1016/j.medcli.2024.06.012

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Erbasan, Funda

Öğüt, Tahir Saygın

Dilbil, Melis

Nokay, Mine

Terzioğlu, Mustafa Ender

Yazısız, Veli
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

stm-asf valid from 2024-11-01

stm-asf valid from 2024-11-01

stm-asf valid from 2024-11-01

stm-asf valid from 2024-11-01

stm-asf valid from 2024-11-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2024.06.012

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.